NASDAQ:ASTH Astrana Health (ASTH) Stock Price, News & Analysis $37.45 -0.56 (-1.47%) Closing price 04:00 PM EasternExtended Trading$37.45 0.00 (0.00%) As of 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Astrana Health Stock (NASDAQ:ASTH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Astrana Health alerts:Sign Up Key Stats Today's Range$37.11▼$38.1750-Day Range$33.55▼$39.7552-Week Range$18.08▼$51.60Volume196,679 shsAverage Volume319,574 shsMarket Capitalization$2.09 billionP/E Ratio22.49Dividend YieldN/APrice Target$49.88Consensus RatingModerate Buy Company Overview Astrana Health, Inc. (NASDAQ: ASTH), formerly known as Apollo Medical Holdings, is a healthcare enablement company focused on helping providers and health plans deliver coordinated, value-based care. The company combines physician networks, care-management capabilities, technology and data analytics to support improved clinical outcomes and more efficient healthcare delivery. Astrana Health’s services include population health management, physician practice support, utilization management, care coordination and clinical analytics. Through its affiliated medical groups, independent physician associations and care-delivery organizations, the company supports primary care and specialty providers while helping manage the healthcare needs of patients, including those with complex or chronic conditions. The company has historically operated primarily in California and has expanded its platform and healthcare relationships into additional U.S. markets. Astrana Health was established as Apollo Medical Holdings and adopted its current name as part of a broader effort to reflect its integrated healthcare and technology platform. Brandon Sim serves as the company’s chief executive officer.AI Generated. May Contain Errors. Read More Astrana Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks89th Percentile Overall ScoreASTH MarketRank™: 4.457735247205 of 5 starsAstrana Health scored higher than 89% of companies evaluated by MarketBeat, and ranked 40th out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingModerate Buy Consensus RatingAstrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on no strong buy ratings, 8 buy ratings, 2 hold ratings, and no sell ratings.Upside PotentialAstrana Health has a consensus price target of $49.88, representing about 33.2% upside from its current price of $37.45.Amount of Analyst CoverageAstrana Health has only been the subject of 4 research reports in the past 90 days.Read more about Astrana Health's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth41.91% Earnings GrowthEarnings for Astrana Health are expected to grow by 41.91% in the coming year, from $1.36 to $1.93 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Astrana Health is 22.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.70.Price to Earnings Ratio vs. SectorThe P/E ratio of Astrana Health is 22.49, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 177.68.Price to Book Value per Share RatioAstrana Health has a P/B Ratio of 2.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Astrana Health's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.95% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in Astrana Health has recently decreased by 5.68%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAstrana Health does not currently pay a dividend.Dividend GrowthAstrana Health does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.54 News SentimentAstrana Health has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Astrana Health this week, compared to 4 articles on an average week. Company Ownership1.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Astrana Health insiders have not sold or bought any company stock.Percentage Held by Insiders20.30% of the stock of Astrana Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Astrana Health's insider trading history. Receive ASTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ASTH Stock News HeadlinesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHOctober 22 at 10:00 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHOctober 20 at 4:15 PM | globenewswire.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 23 at 1:00 AM | Stansberry Research (Ad)Alignment, Astrana Partner to Expand In-Network Care in CaliforniaOctober 19, 2026 | marketscreener.comMBarclays Sticks to Its Buy Rating for Astrana Health (ASTH)October 18, 2026 | theglobeandmail.comAstrana Health (NASDAQ:ASTH) and Agilon Health (NYSE:AGL) Head to Head ComparisonOctober 16, 2026 | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHOctober 15, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHOctober 13, 2026 | globenewswire.comSee More Headlines ASTH Stock Analysis - Frequently Asked Questions How have ASTH shares performed this year? Astrana Health's stock was trading at $24.81 at the start of the year. Since then, ASTH shares have increased by 50.9% and is now trading at $37.45. How were Astrana Health's earnings last quarter? Astrana Health, Inc. (NASDAQ:ASTH) announced its quarterly earnings results on Thursday, August, 6th. The company reported $0.80 EPS for the quarter, topping analysts' consensus estimates of $0.34 by $0.46. The firm's revenue for the quarter was up 48.5% compared to the same quarter last year. Read the conference call transcript. Who are Astrana Health's major shareholders? Top institutional shareholders of Astrana Health include SteelPeak Wealth LLC (0.78%), NorthCrest Asset Manangement LLC (0.29%), Insight Wealth Strategies LLC (0.25%) and State of Alaska Department of Revenue (0.03%). How do I buy shares of Astrana Health? Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/06/2026Today10/23/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 ASTH's financial health is in the Yellow zone, according to TradeSmith. ASTH has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:ASTH Previous SymbolNASDAQ:ASTH CIK1083446 Webwww.astranahealth.com Phone626-282-0288Fax818-839-5190Employees3,000Year Founded1985Price Target and Rating Average Price Target for Astrana Health$49.88 High Price Target$65.00 Low Price Target$37.00 Potential Upside/Downside+33.2%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$0.82 Trailing P/E Ratio22.49 Forward P/E Ratio27.54 P/E GrowthN/ANet Income$22.49 million Net Margins1.05% Pretax Margin1.56% Return on Equity10.30% Return on Assets3.67% Debt Debt-to-Equity Ratio1.05 Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual Sales$3.18 billion Price / Sales0.66 Cash Flow$2.77 per share Price / Cash Flow13.51 Book Value$14.09 per share Price / Book2.66Miscellaneous Outstanding Shares55,740,000Free Float44,422,000Market Cap$2.09 billion OptionableOptionable Beta1.03 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:ASTH) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
